The global market for clinical-trial (CT) management systems is expected to show a compound annual growth rate (CAGR) of 14% between 2014 and 2019, reaching an estimated US$1,848.5 million by the end of that period.
Read MoreEli Lilly has entered into a multi-year research collaboration with T1D Exchange, the first programme launched by US-based non-profit Unitio, to gather real-world insights into the experiences of people with type 1 diabetes.
Read MoreUS-based non-profit The Scripps Research Institute (TSRI) has engaged the Johnson & Johnson Innovation Center in California as its first collaborator for Advance, a new drug-discovery initiative aimed at translating early-stage biomedical research projects into clinical-development candidates.
Read MoreUS-based digital contract research organisation (dCRO) Clinipace Worldwide has signed a preferred-provider agreement under which it will manage several development programmes for Karyopharm Therapeutics, a clinical-stage company developing novel drugs for cancer and other major diseases.
Read MoreThe European Medicines Agency (EMA) has once again extended its deadline for publishing a definitive policy on the disclosure of clinical-trial data for newly licensed medicines.
Read More
